IPO - Traws Pharma, Inc.

Form Type: 424B4

Filing Date: 2024-12-31

Corporate Action: Ipo

Type: New

Accession Number: 000110465924132924

Filing Summary: Traws Pharma, Inc. is offering 608,197 shares of its common stock at a public offering price of $5.103 per share in a bid to raise approximately $2.4 million for clinical and preclinical program development, research activities, and general corporate purposes. This offering is part of a broader strategy following the company's name change from Onconova Therapeutics, Inc. The company also engages in a concurrent private placement, which includes Unregistered Warrants allowing for the purchase of up to 7,230,301 additional shares. As of December 27, 2024, the last reported sale price of Traws Pharma's common stock was $13.42. The company faces risks regarding regulatory compliance for capital raising and listing on Nasdaq due to a stockholder deficit reported at approximately $2.033 million. Without successful compliance, there risks potential delisting and operational challenges. Proceeds will be allocated judiciously under management’s discretion, highlighting an ongoing commitment to core business development aims and addressing market needs in the drug pipeline.

Document Link: View Document